Open Access. Powered by Scholars. Published by Universities.®
Other Pharmacy and Pharmaceutical Sciences Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Acute hyperkalemia (1)
- Acute hyperkalemia managementZS-9 (1)
- Anti-neoplastic agents (1)
- Antineoplastic medications (1)
- Assisted living facilities (1)
-
- CNP (1)
- COVID (1)
- Centralized distribution model (1)
- Certified Nurse Practitioner (1)
- Coronavirus disease (1)
- Distribution (1)
- Diuretic therapy (1)
- HIT (1)
- Healthcare teams (1)
- Heparin-induced thrombocytopenia (1)
- Immunologic dose-response relationship (1)
- Infusion center (1)
- Infusion-related reactions (1)
- Intravenous loop diuretics (1)
- Pharmacist (1)
- Pharmacy (1)
- Pre-treatment medications (1)
- Rural medicine (1)
- Silicates-therapeutic use (1)
- Sodium zirconium cyclosilicate (1)
- Urine sodium values (1)
- Vaccines (1)
- Venous thrombosis (1)
- Virus vaccines (1)
- Zirconium-therapeutic use (1)
- Publication Type
Articles 1 - 6 of 6
Full-Text Articles in Other Pharmacy and Pharmaceutical Sciences
Centracare Launch Of Covid Antiviral Therapy, Jessica Miller, Todd Lemke Pharmd, Dennis Heinen Rph
Centracare Launch Of Covid Antiviral Therapy, Jessica Miller, Todd Lemke Pharmd, Dennis Heinen Rph
Nursing Posters
- Efficiently monitor the limited available stock of oral antiviral COVID therapies during surge states
- Prescribe safely and appropriately
- Dispense to patients close to home.
Assessing Real-World Spot Urine Sodium Values During Continuous Intravenous Infusion Of Loop Diuretics, Rachel Propst, Michael Akers
Assessing Real-World Spot Urine Sodium Values During Continuous Intravenous Infusion Of Loop Diuretics, Rachel Propst, Michael Akers
Pharmacy Posters
- The use of spot urine sodium (UNa)>60 mmol/L as an objective measure to guide diuretic therapy in patients receiving bolus intravenous loop diuretics has been associated with increased weight loss and decreased length of stay.
- There is limited published data evaluating UNa use in patients receiving continuous intravenous loop diuretic infusions.
Evaluation Of Heparin-Induced Thrombocytopenia Antibody Laboratory Use And Anticoagulation Prescribing Patterns, Piper Swanson, Jesse Greenlee, Gregory Schaefer, Paul Huiras
Evaluation Of Heparin-Induced Thrombocytopenia Antibody Laboratory Use And Anticoagulation Prescribing Patterns, Piper Swanson, Jesse Greenlee, Gregory Schaefer, Paul Huiras
Pharmacy Posters
Introduction
- Heparin-induced thrombocytopenia (HIT) is a rare adverse reaction
- Calculating a 4T score prior to ordering a heparin-PF4 immunoassay is recommended. For a score < 4, HIT probability is low and an assay is not advised
- If high suspicion of HIT (4T greater than or equal to 4), an assay should be ordered, all heparin products discontinued, and a non-heparin anticoagulant initiated.
Purpose
- Determine if heparin immunoassay ordering was indicted according to retrospective 4T score
- Assess anticoagulation prescribing depending on the result of the assay
- Serve as a pre-group for a planned perverse post-HIT order set implementation analysis
Nurse Practitioner And Pharmacist Collaboration In Rural Congregate Housing Facility, Kendra Babcock Pharmd
Nurse Practitioner And Pharmacist Collaboration In Rural Congregate Housing Facility, Kendra Babcock Pharmd
Theses and Dissertations
A Certified Nurse Practitioner (CNP) expanded her clinical services to include a project called Senior Transitions (ST). The CNP visited assisted living facilities in the area and conducted rounds on each of the facility’s patients participating in the ST program. The CNP had collaborated with pharmacists in her prior practice setting and wanted to continue doing so in her new practice setting. A pharmacy resident was assigned to participate in co-visits with the CNP at a local assisted-living facility and consulted on any medication-related questions regarding long-term care facility patients which were followed by the practitioner. While conducting co-visits and …
Assessing The Use Of Pre-Treatment Medications In The Management Of Infusion-Related Reactions In An Outpatient Infusion Center, Alyssa Boesche, Alyssa Augst, Bill Kuhlman
Assessing The Use Of Pre-Treatment Medications In The Management Of Infusion-Related Reactions In An Outpatient Infusion Center, Alyssa Boesche, Alyssa Augst, Bill Kuhlman
Pharmacy Posters
Introduction
- Infusion-related reactions (IRRs) are well-known adverse drug reactions of many biological agents and antineoplastic medications
- While typically mild-to-moderate in intensity, IRRs can be severe, with potentially life-threatening consequences requiring urgent interventions
- Appropriate use of pre-treatment medications, such as corticosteroids, antihistamines, intravenous fluids, and antiemetics reduces the incidence and severity of IRRs
Purpose
- Evaluate the use of pre-treatment medications in patients with experienced IRRs at an outpatient infusion center
- Identify opportunities to improve treatment plans and reduce the occurrence of IRRs
Evaluating The Effect Of Sodium Zirconium Cyclosilicate In Acute Hyperkalemia Management, Austin Brandes, Hannah Thompson, Paul Huiras
Evaluating The Effect Of Sodium Zirconium Cyclosilicate In Acute Hyperkalemia Management, Austin Brandes, Hannah Thompson, Paul Huiras
Pharmacy Posters
Introduction
- Sodium zirconium cyclosilicate (ZS-9) can acutely decrease serum potassium (K) levels after one dose and may have favorable side effects compared to sodium polystyrene sulfate (SPS).
- ZS-9 replaced oral SPS in the Hyperkalemia Order Set at St. Cloud Hospital in April 2019
Purpose
- To characterize the acute potassium-lowering effects of one 10-gram dose of sodium zirconium cyclosilicate in conjunction with other potassium-lowering medications